T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease

• Published in: American journal of neuroradiology : AJNR Vol. 38; no. 9; pp. 1799 - 1806
• Main Authors: Schneider, G K, Stroeder, J, Roditi, G, Colosimo, C, Armstrong, P, Martucci, M, Buecker, A, Raczeck, P
• Format: Journal Article
• Language: English
• Published: United States American Society of Neuroradiology 01-09-2017
• Subjects: Brain; Brain - drug effects; Brain - pathology; Child; Contrast agents; Contrast Media - adverse effects; Dentate nucleus; Deposition; Exposure; Female; Females; Gadolinium; Globus pallidus; Humans; Image contrast; Magnetic Resonance Imaging - methods; Male; Males; Meglumine - adverse effects; Meglumine - analogs & derivatives; Nervous System Diseases - chemically induced; Neuroimaging; Nuclei; Organometallic Compounds - adverse effects; Patients; Pediatrics; Pons; Thalamus
• ISSN: 0195-6108; 1936-959X
• DOI: 10.3174/ajnr.a5270

Signal intensity increases possibly suggestive of gadolinium retention have recently been reported on unenhanced T1-weighted images of the pediatric brain following multiple exposures to gadolinium-based MR contrast agents. Our aim was to determine whether T1 signal changes suggestive of gadolinium deposition occur in the brains of pediatric nonneurologic patients after multiple exposures to gadobenate dimeglumine.
Thirty-four nonneurologic patients (group 1; 17 males/17 females; mean age, 7.18 years) who received between 5 and 15 injections (mean, 7.8 injections) of 0.05 mmol/kg of gadobenate during a mean of 2.24 years were compared with 24 control patients (group 2; 16 males/8 females; mean age, 8.78 years) who had never received gadolinium-based contrast agents. Exposure to gadobenate was for diagnosis and therapy monitoring. Five blinded readers independently determined the signal intensity at ROIs in the dentate nucleus, globus pallidus, pons, and thalamus on unenhanced T1-weighted spin-echo images from both groups. Unpaired
tests were used to compare signal-intensity values and dentate nucleus-pons and globus pallidus-thalamus signal-intensity ratios between groups 1 and 2.
Mean signal-intensity values in the dentate nucleus, globus pallidus, pons, and thalamus of gadobenate-exposed patients ranged from 366.4 to 389.2, 360.5 to 392.9, 370.5 to 374.9, and 356.9 to 371.0, respectively. Corresponding values in gadolinium-based contrast agent-naïve subjects were not significantly different (
> .05). Similarly, no significant differences were noted by any reader for comparisons of the dentate nucleus-pons signal-intensity ratios. One reader noted a difference in the mean globus pallidus-thalamus signal-intensity ratios (1.06 ± 0.006 versus 1.02 ± 0.009,
= .002), but this reflected nonsignificantly higher T1 signal in the thalamus of control subjects. The number of exposures and the interval between the first and last exposures did not influence signal-intensity values.
Signal-intensity increases potentially indicative of gadolinium deposition are not seen in pediatric nonneurologic patients after multiple exposures to low-dose gadobenate.